Last $189.53 USD
Change Today +0.57 / 0.30%
Volume 2.1M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Saqib Islam J.D.

Chief Strategy & Portfolio Officer and Senior Vice President, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

44$4,627,497
As of Fiscal Year 2013

Background*

Mr. Saqib Islam has been the Chief Strategy & Portfolio Officer and Senior Vice President of Alexion Pharmaceuticals, Inc. since April 2013. Mr. Islam served as a Managing Director of Morgan Stanley since December 2005. He has 18 years of experience in global business management, with a focus on business development, strategic decision-making and planning, and capital markets. He focus on both executing corporate growth strategies as well as contributing to assessment ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD
School Of Law, Columbia University
Bachelor's Degree
McGill University

Other Affiliations*

Annual Compensation*

Salary$325,000
Total Annual Compensation$325,000

Stock Options*

Restricted Stock Awards$2,230,750
All Other Compensation$139,652
Unexercisable Options75,000
Unexercisable Options Value$3,273,750
Total Value of Options$3,273,750
Total Number of Options75,000

Total Compensation*

Total Annual Cash Compensation$724,652
Total Short Term Compensation$325,000
Other Long Term Compensation$2,370,402
Total Calculated Compensation$4,627,497
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $189.53 USD +0.57

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$876.9K
Stephen Edward Foots Chief Executive Officer, Executive Director, Chairman of Group Executive Committee, Member of Risk Management Committee, Member of Routine Business Committee, Member of Nomination Committee, Member of Finance Committee and Member of Group Safety, Health & Environment Steering Committee
Croda International plc
535.0K GBP
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer and Labour Director
Symrise AG
€1.1M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
6.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.